|
RB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.652120E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.302020E-01 |
| Normal-vs-Stage2 |
9.760000E-02 |
| Normal-vs-Stage3 |
4.973600E-02 |
| Normal-vs-Stage4 |
6.115400E-01 |
| Stage1-vs-Stage2 |
4.779800E-01 |
| Stage1-vs-Stage3 |
3.857400E-01 |
| Stage1-vs-Stage4 |
9.250200E-01 |
| Stage2-vs-Stage3 |
9.680200E-01 |
| Stage2-vs-Stage4 |
5.432200E-01 |
| Stage3-vs-Stage4 |
4.995800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.002360E-01 |
| Normal-vs-AfricanAmerican |
2.294300E-02 |
| Normal-vs-Asian |
9.632600E-01 |
| Caucasian-vs-AfricanAmerican |
1.864770E-01 |
| Caucasian-vs-Asian |
6.358600E-01 |
| AfricanAmerican-vs-Asian |
3.965600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.343900E-02 |
| Normal-vs-Female |
4.014100E-02 |
| Male-vs-Female |
6.323000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.860600E-01 |
| Normal-vs-Extreme_Weight |
4.069000E-01 |
| Normal-vs-Obese |
7.902400E-03 |
| Normal-vs-Extreme_Obese |
5.975400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.929800E-01 |
| Normal_Weight-vs-Obese |
5.797800E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.094000E-01 |
| Extreme_Weight-vs-Obese |
9.743600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.942800E-01 |
| Obese-vs-Extreme_Obese |
4.584200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.898000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.777900E-04 |
| Normal-vs-Age(61-80Yrs) |
5.354200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.838400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.868600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.288800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.702200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.099000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.914100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.362800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.827700E-02 |
| Normal-VS-Type2 PRCC |
5.157200E-01 |
| Normal-VS-KIRP CIMP |
1.009430E-01 |
| Normal-VS-Unclassified PRCC |
6.781900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.875200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.264200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.896400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.622800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.253870E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.269600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.291400E-01 |
| Normal-vs-N1 |
8.654200E-02 |
| Normal-vs-N2 |
1.537570E-01 |
| N0-vs-N1 |
1.085190E-01 |
| N0-vs-N2 |
3.753600E-01 |
| N1-vs-N2 |
1.291220E-01 |
|
|
